A Multinational, Multi-center, Randomized, Double-blind, Active Comparator, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Donepezil Transdermal Patch in Patients With Alzheimer's Disease
Phase of Trial: Phase III
Latest Information Update: 14 May 2018
At a glance
- Drugs Donepezil (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors ICURE
- 08 May 2018 Planned End Date changed to 31 Jul 2019.
- 28 Feb 2018 Status changed from not yet recruiting to recruiting.
- 28 Sep 2017 Planned initiation date changed from 7 Jul 2017 to 1 Nov 2017.